Merck shook the field with news that people on verubecestat scored worse than those on placebo – find out more in this post from AlzForum
The David Hague Early Career Investigator of the Year Award is presented each year to the most outstanding early career researcher in the field of biomedical dementia research.
Dementia Special Issue: Patient and Public Involvement in Dementia Research: Moving from Proving to Improving
Eight articles that report on the diverse methods and impact of PPI
Seeking researchers to help identify research gaps, and support writing groups to prepare grant applications for clinical studies and health and social care research.